Remove 2015 Remove Doctors Remove Sales
article thumbnail

Medical Sales Representative Salary In Malaysia

Contrarian Sales Techniques

Medical Sales Representative (also known as MSR or MR or Medical Rep) in Malaysia is a sophisticated and confident salesperson who know the medical jargon to promote prescription and over-the-counter medicines. Medical sales are a popular career choice for professionals as they often offer rapid career growth.

article thumbnail

Aesthetic Medical Sales With The Lauren Brown ā€“ Medical Sales Influencer

Evolve Your Success

Confidence, clinical expertise, and genuine connections are the key ingredients to thriving in the dynamic world of aesthetic medical sales. Don’t miss the chance to learn from the best in the business ā€“ Lauren Brown ā€“ and explore how you too can excel in the exciting world of medical sales. Tune in now! Iā€™m excited. It was hard.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Novartis agrees $245m settlement over Exforge generics delay

pharmaphorum

The complaint claims that Par agreed not to launch its generic, in return for Novartis not launching a patent infringement suit and agreeing not to launch its own authorised generic of the drug until 30 March, 2015, giving Par a valuable six months to sell its generic unopposed in the market.

Retail 52
article thumbnail

5 Core Tenets of HCP-focused Point-of-Care Marketing

PM360

In the past, the best way to deliver brand messages to prescribers was obvious: send your army of field-based sales representatives to potential high-volume prescribers and sell, sell, sell. These digital wallboards had a smaller footprint within the doctorsā€™ offices, but delivered the messages with much more dynamic effect.

article thumbnail

Comparison of Humira biosimilars in the US and Europe

Pharmaceutical Technology

Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. In addition, insurersā€™ contracting practices can help preserve the sales of brand-name drugs. Further, there remains scepticism on the efficacy and safety of biosimilars.

article thumbnail

Teva asks SCOTUS to overturn ā€œskinny labelā€ verdict on GSK drug

pharmaphorum

Teva launched its first generic in that year with a skinny label that excluded the heart failure use, as it was covered by a use patent that expired in 2015.

article thumbnail

Capturing progress in haemophilia care

pharmaphorum

Lutz Bonacker joined CSL Behring in 2006 as Head of Global Commercial Development Coagulation and was promoted to his current position in 2015. He is responsible for the management of 14 European affiliates in the achievement of their sales goals and business objectives. References. Berntorp E., Haemophilia. Nature Reviews.